News
The average Ayala Pharmaceuticals price target of $15 implies 607.5% upside potential.Analyst price targets range from a low of $12 per share to a high of $18 per share ... As a company, it is not ...
REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage onc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback